Your pitch was sharp. Your deck told a compelling story. The product demo landed. The partner leaned in and said the words founders wait months to hear: "We'd like to move to diligence."

That's when most founders exhale. It shouldn't be.

The pitch gets you in the room. Diligence decides whether you leave with a term sheet or a polite pass. And in 2026 -- with investors more selective than they've been in years, capital concentrating around companies with documented defensibility, and M&A counsel publicly stating that IP is the most critical diligence category for technology companies -- your IP folder is doing more work than you think.

The problem is that most founders have never seen their IP through investor eyes. They built a company. They filed some things. They assume the legal pieces are handled. They are not prepared for what an experienced diligence team actually looks for -- or what it means when they find something they don't like.

This post changes that. Here is exactly what investors and acquirers see when they open your IP folder -- and the five findings that change the outcome of your deal.

First Understand What Diligence Is Actually Trying to Accomplish

Investors are not auditing your IP to admire it. They are trying to answer one critical question: are we buying a defensible asset?

First, Investors are checking for obvious red flags -- ownership gaps, missing assignments, early conflicts, and basic questions, such as what patent are filed and have any been granted? 

Then, Investors should be reviewing the patent applications (or granted patents) in more detail -- claim scope, prosecution history, freedom-to-operate exposure, jurisdictional coverage, and the alignment between what the patents say and what the product actually does. The bigger the check, the deeper the dig.

In M&A, it is the most intensive version of this process. Acquirers are not just evaluating what you have -- they are evaluating what they are inheriting. Every unresolved IP issue becomes a negotiating lever, an escrow demand, a valuation haircut, or a reason to restructure the deal entirely.

What experienced diligence teams have seen, across hundreds of deals, is that IP problems almost never appear all at once. They surface piece by piece -- a missing contractor assignment here, a trademark registered in the wrong entity there, a provisional that was never properly converted. Individually, each issue seems manageable. Together, they tell a story about a company that didn't take IP seriously. That story has a cost.

Question 1: Who Actually Owns This?

This is the first question and the most important one. It sounds simple. It rarely is.

Ownership gaps are the most common IP problem investors find in early-stage companies, and they are among the most damaging. The most typical scenarios: a co-founder who left in year one before an IP assignment was executed. A contractor who built a core feature without signing an agreement that transferred rights to the company. A PhD advisor or university lab that contributed to the foundational technology and whose institution may have a claim on it. An employee who did early development work on a personal laptop, before they were officially on payroll.

Each of these creates what attorneys call a chain-of-title defect. The company believes it owns the IP. The legal record does not confirm it. And in diligence, that gap does not go unnoticed.

The question investors are asking is not just "do you have patents?" It is "does the company -- this entity, this cap table -- unambiguously own the IP it was built on?" If the answer requires more than a clean document trail to establish, the deal slows down, the price gets renegotiated, or the conversation about corrective filings begins before any term sheet is signed.

Fix this before you open a data room. Every founder, co-founder, early employee, advisor, and contractor who contributed to core technology should have a signed IP assignment agreement on file. If gaps exist, they can often be remediated -- but doing it proactively is far less expensive, in every sense, than doing it under investor scrutiny.

Question 2: What the Patents Actually Cover

Not all patents are equivalent. Investors who have been through enough diligence cycles know this. Many founders do not.

The existence of a patent filing -- pending or granted -- is a starting point, not a conclusion. What experienced reviewers assess is the relationship between the claims in the patent and the product the company is actually selling. Broad, well-drafted claims that map cleanly to the core product create real defensive value. Narrow claims that cover a critical feature the product can be equally compelling.  But patents based upon minor or optional details may have little to no value.

What investors really want to see is coherence. They want the IP portfolio to tell the same story as the pitch deck -- here is the innovation, here is why it is defensible, here is how the claims protect the actual competitive advantage. When those three things align, IP becomes a valuation driver. When they don't, it becomes a liability.

And even more importantly, a coherent and honest story speaks volumes as to the honesty and competence of the Founder.  A glowing pitch that does not include patent to back it up tells investors that the Founder cannot be trusted, either because of dishonesty or incompetence.

Question 3: Freedom to Operate -- The Question Nobody Asks Until It's Too Late

Freedom to operate -- or FTO -- is the analysis of whether your product, as it currently exists, infringes on someone else's valid patent. It is not the same as having your own patents. You can have a strong patent portfolio and still be infringing a competitor's IP. These are separate questions.

At the seed stage, most investors do not require a formal FTO opinion. But by Series A, and certainly in any M&A context, the absence of FTO analysis on core product features becomes a material concern. If a key revenue-generating feature potentially infringes a third-party patent and no one has formally assessed that risk, investors face an unknown liability. Unknown liabilities do not get ignored -- they get priced in, usually at the founder's expense.

The scenario that kills deals is not usually active litigation. It is the discovery, during diligence, that the company has never asked the question. That a core product feature sits in a patent landscape the team has never mapped. That there are issued patents held by a well-funded competitor that arguably cover what this company is selling. This is not a hypothetical concern. It is a recurring finding in technology diligence, and it is one of the cleanest reasons an investor or acquirer walks away or demands indemnification.

A FTO search is not an optional document, but an essential part of the due diligence that every sincere Founder should take very seriously.

Question 4: The Trademark and Brand Story

Investors look at trademarks for two reasons. First, because a strong and well-protected trademark is a company’s most valuable business asset. Second, because weak trademarks, or brand names that have not passed a clearance search, can cause massive problems later, including very expensive litigation, and even the nightmare scenario of having to completely rebrand the company.  And this means changing products and packaging, all new web pages and social media, and the destruction of potentially years of customer goodwill.

The red flags are consistent: a trademark registered to a holding company that no longer exists, or to a founder personally instead of the operating entity. A mark registered in one class that doesn't cover the company's actual products or services. A company that has been using a name for three years without ever filing -- only to discover, during diligence, that a similar mark is already registered by a competitor in the same space.

Another common problem is a company that has developed it’s brand in some markets, but has not protected it in others – for example, the trademark in cleared and registered in the US, but no steps have been taken in the EU, where the company intends to sell.  Your brand names need to clear in all of the jurisdictions that you may be selling.

A clean trademark picture is not complicated to establish. It requires intentionality, not a massive legal budget. Registrations in the right classes, in the right jurisdictions, owned by the right entity. It is the kind of thing that takes a short time to get right and months to clean up if it goes wrong.

Question 5: The Consistency of the Story

This is the one founders least expect, because it is not about any single document. It is about whether all the documents tell the same story.

Experienced diligence teams are not just reviewing individual IP assets in isolation. They are looking at the whole picture -- and they are asking whether it is coherent. Do the patents cover the product? Does the product align with the pitch? Does the trademark cover the brand as it is actually being used? Do the employment agreements confirm that the people who built the core technology assigned their work to the company? Is the entity that owns the IP the same entity on the cap table?

When the answer to all of those questions is yes, IP diligence becomes a value confirmation exercise. Investors walk away with higher confidence in what they are buying.

When the answers are inconsistent -- when the patents describe version one of a product that no longer exists, when the trademark is in one entity and the patents are in another, when key contributors never signed assignments -- the picture that emerges is of a company that built without thinking about defensibility. That picture does not disappear because the founder explains it away in a call. It lives in the data room, and it shapes every subsequent conversation about price, terms, and risk.

What to Do With This

You do not need a perfect IP portfolio to raise capital. Most investors understand that early-stage companies are works in progress. What they cannot get past is a portfolio that suggests no one was ever thinking about this strategically.

The founders who come into diligence without surprises are the ones who approached IP the same way they approached their product roadmap: with intention, with a plan, and with someone in their corner who understands both the legal landscape and the business they are building.

Before your next investor conversation, take an honest look at what your IP folder actually says. Not what you think it says. What an experienced diligence team will read when they open it for the first time.

If you are not sure what they will find, that is the conversation worth having now.